3^rd World Conference on Breast and Cervical Cancer September 24-25, 2018 Abu Dhabi, UAE

Dr. Matar is one of the most well-respected influencer advising public and private sector organizations, on sustainable healthcare, community empowerment, and youth development. Dr. Matar is a strong advocate of empowering the community in healthcare and has a very strong background and expertise in sustainable development, strategic planning and leadership, public policy and advocacy. She is the first woman Director General of Community Development Authority (CDA), which undertakes to formulate social policies and deliver social services that are in line with and contribute to the achievement of the social development objectives of Dubai Strategic Plan 2007 – 2015, launched by H.H. Sheikh Mohammed Bin Rashid Al Maktoum on February 3rd, 2007. In 2005, Dr. Matar was the leader of the executive team that set up social development strategies for the Dubai Strategic Plan.

Genetics

A highly accomplished visionary executive and strategist with 15+ years of achievement and proven success with owning and operating multi-million dollar corporations. As CEO and Director of Operations in various companies, Mr. Agad has helped in the growth of sales while providing leadership in the corporate and retail industries, at both a domestic and International level. Mr. Agad is known to thrive at being tenacious in building new businesses, strategic positioning, development, and strategic planning with both startup and growth organizations while forming strong relationships with key individuals. Mr. Agad is a results-oriented, decisive leader with proven success in the new market identification, as well as strategic thinking, and problem-solving. Mr. Agad thrives in dynamic and fluid environments while remaining pragmatic and focused, and has achieved a number of accomplishments in planning and leading comprehensive marketing strategies in support of business and economic goals, ideas, and objectives.

Oncology, Proton Cancer Therapy

Brianne Joseph is an award-winning Private Investigator, Best-selling author, keynote speaker, and breast cancer survivor. She is the Owner at Sly Fox Investigations - an all female, six-figure Private Investigation agency, owner of Punk Azz Cancer- a breast cancer empowerment brand, and is author to inspirational book ‘Punk Azz Cancer, How Dare You!’ A recognized leader, Brianne was previously the Region II Director of the Louisiana Private Investigators Association, was named the 2011 'Investigator Of The Year ' by the National Association of Investigative Specialists, and was awarded 2017 ‘Best Private Investigator in New Orleans’ by Expertise. Brianne is also the State Leader for the Young Survival Coalition- an organization that provides resources to breast cancer survivors under 40.

Breast Cancer, Investigation, Speaker

Dr. Yan-Gao Man holds a Medical degree in Western Medicine, Master degree in Microbiology, and PhD in Cell Biology/Anatomy. He completed postdoctoral training in Cancer Biology at National Cancer Institute, NIH, USA. Dr. Man served as the Director of Gynecological and Breast Research Laboratory of Armed Forces Institute of Pathology and American Registry of Pathology for 16 years. Currently, he serves as Adjunct Distinguished Scientist at Hackensack University Medical Center, NJ, USA, the Vice President for Research & Collaboration at South Hospital of Nanjing, China, visiting professor of China Key Laboratory of Sub-health Intervention, the Editor-in-chief for several international medical journals, and the Chairman of Board Directors and Secretary General of International Union for Difficult-to-treat Diseases (www.iudd.org; www.canceraging.org; www.canceraging.org/2016/). Dr. Man has authored and co-authored over 250 published articles and abstracts in the cancer field, 46 non-scientific articles, 4 book chapters, and 14 novel protocols for molecular and immunohistochemical assays. Dr. Man’s medical practice and research are primarily focused on the mechanism of cancer invasion and metastasis. He is the originator of most updated hypotheses for cancer invasion and metastasis; his hypothesis of cancer invasion has been recognized as “more compatible with existing experimental evidence than the traditional “protoelytic enzyme” theory” [Pandey PR et al. Front Biosci. 15: 226–236, 2011], and his hypothesis of cancer metastasis is the only one that can reasonably explain all major steps of cancer metastasis among all existing theories.

Cancer Biology,Gynecological and Breast Research,Microbiology, Cell Biology/Anatomy.

Professional Activities for IASP: • Former International Council member in IASP, 2008-2014. • Coordinator of the Pain School Project (IASP project) for post graduate degrees in pain, aesthesia, and physical medicine, 2011-2018. • Founder of the Egyptian Society for the Management of Pain, 1982; President (ESMP, IASP Chapter), 2009-2015. • Member in the Developing Countries Working Group, 2008-2012. • Winner of IASP grant for pain education in developing countries twice: i. Pain education in remote location for the G.P in Egypt, 2006. ii. Opioids Legislations for the Pharmacists and Pharmacy Students in Egypt, 2009 • Representative of IASP in the following meetings, 2009-2015: i. Official visiting professor representing IASP in, and congresses in pain in Bangladesh, 2015, , Albania, 2013, Nigeria, 2011. ii. WHO-EMRO for management of cancer pain, in Fez, Morocco, 2009. • Pushed the establishment of some IASP chapters (Libya, Ghana and Jordan), and national pain societies (Sudan, Saudi Arabia and Iraq) in Africa and Middle East, 2006-2011. • Co-designer of the pain questionnaire and pain survey done by the Developing Countries Working Group, 2008. • Member in the taskforce of the IASP for pain education in developing countries, 1999-2012. • Regular attendant of the IASP World congress on Pain since 1984 – 2014 except, 1996 and 2016 • Member of the International Association for the Study of Pain (IASP), 1984 to date.

Anesthesiology, Pain Medicine,physical medicine

Dr. Sawsan A. S. Al Madhi has more than 14 years progressive leadership skills and experience in strategy, operations and administration for the not-profit charitable sector. Currently working with one of the most reputable charities in the UAE as the Director General for Friends of Cancer Patients, Dr. Sawsan’s role is to supervise the continuing refinement and expansion of the organizational objectives which include: providing high quality services, organizing fundraising activities, developing ,planning and executing nationwide awareness programs and campaigns through collaboration with a vast network of national and international, governmental and private sector organizations.

Internal Medicine, Healthcare management

Dr. Marveh Rahmati is currently working as an Assistant professor of Cancer Biology Research Center, Tehran University of Medical Sciences, Tehran, Iran. She obtained her PhD in medical biotechnology from Tabriz University of Medical Sciences, Iran and spent her Sabbatical research in national university of Ireland, Galway. Dr. Marveh Rahmati research is mainly focused in mechanisms of cancer drug resistance through apoptosis or autophagy pathways, study of nanoparticles in targeted therapy, epidemiology and epigenetic study of cancers in Iran. In 2008, she received her master’s degree in the field of microbiology from Alzahra university of Tehran, Iran. She has won “the young scientist awards” in 2009 from Iranian Society of Microbiology, “the best researcher awards” and “top students award” in 2008 from Alzahra university. Dr. Rahmati published 18 articles in national and international journals, one-chapter book and one Persian book. She worked as reviewer for some articles in different journals.

Cancer Biology, Epidemiology and epigenetic study of Cancers, Microbiology

Dr. Mahir Jallo, Clinical Professor of Medicine, Head of Department & Consultant, Internal Medicine - Diabetes & Endocrinology in Gulf Medical University – UAE & Faculty in the Canadian Academy of Natural Health – Toronto – Canada. Granted his MBChB from Mosul Medical College - IRAQ, his postgraduate Board Certification in Internal Medicine CABM from the Arab Board, his Fellowship of American College of Endocrinology FACE, & and Diploma in Dyslipidemia from Boston University School of Medicine from USA . Invited speaker in many National & International conferences & CME programs. Organizer of the annual GMU Diabetes & Endocrinology Conference in UAE since 2012. Member of organizing committees for many international conferences in US & Europe. Editorial Board Member & reviewer for many international Diabetes & Endocrinology journals, with many publications in medical periodicals and medical conferences abstract & Active Principle Investigator in many National & International Clinical studies. Member of many national & international medical societies & associations, AACE, EASD, ISPAD, ESE & European Atherosclerosis Society. Awarded twice A Special Honor & Award in recognition of the exemplary achievements in the field of Internal Medicine & Endocrinology and for the invaluable service to the community.

Internal Medicine, Diabetes & Endocrinology

Dr. Xiaoning Peng is currently working as a Professor and vice dean of Hunan Normal University School of Medicine. He obtained a PhD in the department of internal medicine at central south University Xiangya medical school, People’s Repulic of China. Dr. Xiaoning Peng research is mainly focused cancer genetics, microarray data analysis, genetic algorithm development and application, evidence-based medicine, tumor genome data mining and precision medicine. Dr. Xiaoning Peng is the principal investigator on National Science Foundation of China (NSFC) and pharmaceutical-funded studies and published more than 30 articles in international journals. He worked as reviewer for many articles and sits on several Editorial boards. He is Vice Chairman of Hunan Province Association for Pathophysiology, Vice chairman of Hunan provincial health statistics Committee and Academic leader of key disciplines of basic medicine of Hunan Province, People’s Repulic of China.

Cancer Genetics, Microarray Data Analysis, Genetic Algorithm Development and Application, Evidence-based Medicine, Tumor genome data mining and precision medicine

Evgenia Aleksandrova (more famous with her former family name Adarska) is a former patient with Breast Cancer. She has 19 years’ experience in this area as a patient consultant and navigator of patients in the health theme in Bulgaria. She is a chairwoman of Association of a cancer patient and their Friends (APOZ and Friends) in Bulgaria, the history of this NGO is 15 years. Her organization is a member of all significant cancer patient organizations as a UICC, ECPC, Europa Donna, Europa Colon, Europa Uomo, INCA and other. She has her expertise in evaluation and passion for improving the health and well-being of cancer patients and a good experience of the developing of the framework of cares of this patients. She works very well with the government structures and scientist and professional organizations. Her open and contextual evaluation model based on responsive constructivists creates new pathways for improving healthcare. She has built this model after years of experience in research, evaluation, teaching, and administration both in hospital and education institutions. The philosophy of her organization is based on the fourth-generation evaluation (Guba& Lincoln, 1989) which is a methodology that utilizes the previous generations of evaluation: measurement, description, and judgment. It allows for value-pluralism. This approach is responsive to all stakeholders and has a different way of focusing. Her model of unmedical care of patients with BC, based on the standard of unmedical cares (2009), includes a center of Unmedical care in hospitals and specialized complex rehabilitation program of BC patient, paid by the government. Mrs. Aleksanrova, famous as Adarska, has National and International awards for her contribution of developing of cancer care. Her last efforts are for the building of the anticancer plan on the National level.

Breast Cencer